The Ocular Immunology Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Amyloid. 2012 Dec;19(4):201-3. doi: 10.3109/13506129.2012.724035. Epub 2012 Sep 13.
We report a 57-year-old man with pathognomonic bilateral vitreo-lenticular amyloid opacities (pseudopodia lentis) in whom a novel transthyretin (TTR) mutation was identified. The patient presented due to bilateral floaters. The vitreous cavities of both eyes showed course, fibrilar opacities attached to the posterior lens surface with pseudopodia. There was a history of bilateral carpal tunnel syndrome. Nerve conduction studies showed upper and lower limb axonal polyneuropathy. Magnetic resonance imaging of the brain and spinal cord, renal and cardiac function were normal. Vitreous and conjunctival biopsies confirmed the diagnosis of TTR-related amyloidosis. Genetic analysis of exon 2 of the TTR gene revealed that the patient was heterozygous for a single nucleotide substitution c.160 A>G, resulting in replacement of arginine with glycine at position 34 of the mature protein (Arg34Gly). Five years later the patient developed increasing sensory and motor neuropathy of both lower limbs, and neovascular glaucoma in one eye. We hypothesize that the reason for his neovascular glaucoma was retinal ischaemia secondary to amyloid retinal vasculopathy.
我们报告了一例 57 岁男性患者,其具有特征性的双侧玻璃体晶状体淀粉样蛋白混浊(假晶状体),并发现了一种新的转甲状腺素蛋白 (TTR) 突变。该患者因双侧飞蚊症就诊。双眼玻璃体腔均可见附着在后晶状体表面的纤维状混浊物,呈伪足状。患者有双侧腕管综合征病史。神经传导研究显示上下肢轴索性多发性神经病。脑和脊髓磁共振成像、肾脏和心脏功能均正常。玻璃体液和结膜活检证实了 TTR 相关性淀粉样变性的诊断。TTR 基因外显子 2 的基因分析显示,患者为杂合子,存在 c.160 A>G 单核苷酸替换,导致成熟蛋白第 34 位精氨酸被甘氨酸取代(Arg34Gly)。五年后,该患者出现双侧下肢感觉运动神经病加重,并出现一眼新生血管性青光眼。我们假设他的新生血管性青光眼的原因是由于淀粉样视网膜血管病变导致的视网膜缺血。